 SHELTON, CT ACCESSWIRE April 6, 2020 NanoViricides, Inc. NYSE American:NNVC the Company a leader in the development of highly effective antiviral drugs based on a novel, patented, nanomedicines platform, reports that U.S. Senator Richard Blumenthal visited the Companys facility in Shelton, Connecticut, on Tuesday, March 31, 2020. The Honorable Senator Blumenthal visited the Company to receive an update regarding the coronavirus COVID-19 drug development program and to tour the cGMP-capable manufacturing facility. 